chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case reported by a physician, describes the occurrence of product administered at inappropriate site (site of the injection more towards the triceps than the deltoid muscle) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Apr 28, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 28, 2021, patient experienced product administered at inappropriate site (site of the injection more towards the triceps than the deltoid muscle). At the time of the report, product administered at inappropriate site (site of the injection more towards the triceps than the deltoid muscle) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. Reported information included injection taken towards the triceps than the deltoid muscle.
This spontaneous report as received from a consumer (patient's mother) refers to a male patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL 9, injection (exact dose, route of administration, anatomical location, lot # and expiration date were not provided). The patient's mother reported, that on an unknown date, her son would miss the second dose of GARDASIL 9. Additional information is not expected due to lack of the reporter's contact details.
Pt developed itchy rash 04/17/2001; seen on 04/20/2001 with 8-10 vesicles ?? side chest and groin ???
Information has been received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. Information about medical history, concurrent condition and concomitant medication. On an unknown dates the patients were vaccinated with doses of improperly stored ROTATEQ (lot # K020181 with expiration date of 24-JUN-2016; strength, dosage, frequency and route unspecified). No symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
5-6 hrs post injection, patient developed low grade fever, abdominal pain, nausea and body aches. She received 3rd HPV and MENVEO.
pt claimed she got pneumonia after the vaccine and recovered after going to the doctors and taking her meds
Began with pain at injection site then splotchy redness- by day 2 a lot of pain to touch, swelling some which began at bicep then moved down and setteled at elbow. By day 3 swelling, and redness had greatly improved.
Got shingles two weeks after the shot; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a elderly female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's daughter/son. The age at vaccination was not reported. The reporter stated that two weeks after the patient got the Shingles shot, she got shingles. The reporter stated that it was horrible for her because she was in her 70's. The reporter stated that this was not a good idea. The follow up would not be possible as no contact details were available. This case had been linked with case US2021AMR195377, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR195377:Same reporter.
it did make me sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (180628). The reporter is the patient.  A 26-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "it did make me sick".  Clinical course: Reporter is not a Healthcare professional. Pfizer vaccine was a good one but it didnt make it any worse because the first shot didnt make the symptoms go back as well so they had a lot more to say but it did make her sick so she was glad that they didnt have any symptoms and she dont think it would make a big deal if it did not cause the virus but she guess.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Left upper arm with redness 1" x 2 1/4" area. Will do ZYRTEC BID and cool compresses.
pT. STATES GENERALIZED RASH AND ITCHING OF SKIN SINCE DAY AFTER hEP b VACCINE WAS ADMINISTERED.  pT. HAD RECEIVED tWINRIX ONE MONTH PRIOR WITH NO SIDE EFFECT.
This is about my left arm and hands and fingers, the side I received my vaccine. The second night after I got my shot I was laying in bed and I could not move my arm really and it was having weird spasms like zaps going down my arm.  My arm had and dead weight feeling to it and I could barely move it I started panicking. I tried to calm down but I couldn't stop thinking how abnormal it felt. I have tried to relax it because I was theorizing it could be from inflammation (sort of like a trigger finger affect). It's very upsetting because the feeling hasn't gone away. I can move my arm and hands and fingers better now but I still have this tingly feeling in my funny bone radiating to my armpit and down to my finger tips especially my pinky and ring finger. My muscles keep tightening in my forearm. I will see a doctor as soon as possible.  To go into more detail: It feels like there is a rubber band around my funny bone area, like my funny bone is constantly being hit. A constant buzz. It is hard for me to move my pinky and ring finger on my hand, the best way to describe it is sort of like a numbness and those two fingers move together more now. My coordination is off. It's in pain especially because of the tightening feeling and the palm of my hand has a clenching going on.   When you wake up and find you have been sleeping on your arm and at first it feels normals and then as the blood rushes to it it starts to tingle - it sort of feels like that but all the time right now. It's got a dead weight feeling.  It has been ten days since my vaccine.  Thanks for reading.
pt recvd flu vax & exp rt facial paralysis in eyelid, forehead, cheeks, lips & chin 2 days p/vax;
Severe body and muscle pain with trouble walking. Headache, dizziness, nausea, lump formed in my left armpit, and couldn?t stay awake with low fever of 100.1
Upper arm was very sore from the day of vaccine.  On Dec 14, 2016, I noticed a circle the size of a half dollar at the injection site that was completely red.  Dr. saw me immediately and said it appeared to be warm and infected.  She put me on Bactrim for five days.  Two days after going off the antibiotic, my muscle in the same arm became very painful.  I again went to see Dr.  She thought the muscle was inflamed and suggested an ibuprofen med to take away the inflammation.  As long as I take Advil gel at night, I can sleep.  The pain and soreness in the muscle comes and goes, but most noticeable at night.
Initial and follow up information has been received from a medical assistant and a physician concerning an approximately 25 year old female who on 30-OCT-2006 was vaccinated IM with the first 0.5 ml dose of GARDASIL (Lot#653937/0637F). On 02-JAN-2007, the patient was vaccinated IM with the second 0.5 ml dose of GARDASIL (Lot#654389/0961F). In approximately 2007, the patient had a "problem with her heart" between the second and third doses. On 11-APR-2008, she was vaccinated IM with the third 0.5 ml dose of GARDASIL. The patient sought medical attention by an physician other than the reporter. At the time of the report, the patient outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Patient received moderna Booster dose 5 ml; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Patient received moderna Booster dose 5 ml) in an 81-year-old female patient who received mRNA-1273  (batch nos. DR14386, RA4945 and RA4945) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 28-Dec-2021 and Arrhythmia from 28-Dec-2021 to 01-Feb-2022. Concurrent medical conditions included Type 2 diabetes mellitus since 08-Oct-2012, Hypertension and Depression. Concomitant products included ROSUVASTATIN from 14-Nov-2015 to an unknown date for Cholesterol, ESCITALOPRAM from 05-Mar-2013 to an unknown date for Depression, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) from 10-Aug-2012 to an unknown date for Diabetes, METOPROLOL from 08-Apr-2011 to an unknown date for Hypertension, OLMESARTAN MEDOXOMIL from 10-Aug-2012 to an unknown date for an unknown indication.   On 18-Feb-2021 at 2:00 PM, the patient received first dose of mRNA-1273  (unknown route) 1 dosage form. On 18-Mar-2021 at 1:00 PM, received second dose of mRNA-1273  (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2022 at 10:00 AM, received third dose of mRNA-1273  (unknown route) dosage was changed to 5 milliliter. On 16-Feb-2022 at 10:00 AM, the patient experienced ACCIDENTAL OVERDOSE (Patient received moderna Booster dose 5 ml). The patient was treated with IBUPROFEN from 29-Dec-2021 to 02-Jan-2022 at a dose of 600 milligram every eight hours. At the time of the report, ACCIDENTAL OVERDOSE (Patient received moderna Booster dose 5 ml) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Dec-2021, Polymerase chain reaction: positive (Positive) Positive, Source of sample anterior swab. On 21-Jan-2022, Polymerase chain reaction: negative (Negative) Negative, Source of sample Ant nasal swab.         Historical vaccine included Shingles 50 mg in shoulder on 26-Nov-2021 and 28-Jan-2022. It was reported that route and body site was reported as shoulder.   This case was linked to MOD-2021-039332, MOD-2022-464934 (Patient Link).
High heart rate; Heavy and early onset of menstrual cycle; Heavy and early onset of menstrual cycle; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0151) via an unspecified route of administration in the left arm on 07Apr2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 20Mar2021 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 14:00, the patient experienced high heart rate for 24 hours, heavy and early onset of menstrual cycle. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of high heart rate was resolved on 08Apr2021 and the clinical outcome of heavy and early onset of menstrual cycle was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Pt received ADACEL 5/11, pt called 5/13 to report body aches, pain at injection site, feverish feeling. Pt spoke to PCP and.
Day 3 after the injection large golf ball sized swelling on left hand. Swelling has started to subside on it's own. Tingling, chills.
Less than 24 hrs of taking a shot, PT started feeling sick to the stomach and headache after headaches. Also broke out with 4-5 nickel size bumps on rear end.
Shingles; Mom has some kind of virus on her body; This is a spontaneous report from a non-contactable consumer or other non hcp via Pfizer sponsored Program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 10May2021 (Batch/Lot number was not reported) as first dose, single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced shingles on an unspecified date in May2021 and had some kind of virus on her body on an unspecified date in 2021. The reporter stated that her mother received her first vaccine on 10May2021 and developed shingles afterwards and wanted to know if she can take the second vaccination, scheduled on 31st, the next Monday. At the time of reporting, patient was receiving like a viral medication (Unspecified Medication; Intent: Treatment). Reporter did not know what it does to the shingles. Patient had a seven days prescription plus she had another months of the medication for this. Reporter mentioned that patient never had these things before, reporter did not want to say that was caused by the vaccine. Patient went to the Doctor yesterday and they find out that there was shingles. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Menstrual cycles completely stopped; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021(at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on Mar2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 01Jun2021, the patient's menstrual cycles completely stopped. Her cycles had now vanished. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date, the patient underwent nasal swab test and the result was unknown. Since the vaccination, the patient had been tested for COVID-19.The clinical outcome of the event menstrual cycles completely stopped was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Patient given Zoster vaccine IM instead of Sub Q. Patient informed to pay close attention for adverse reactions. No symptoms or signs noted at time of vaccination.
Weakness/Fatigue starting the evening of the injection and persisting for about 48 hours. Chills/fever, nausea, and lightheadedness starting the next morning. Loss of consciousness (Uncertain if it was vasovagal syncope or seizure) 10:30 pm the next day.
Lymphomatoid papulosis type A; Dose 2, Progressed(Multiple papules); In the initial version the case was assessed as Invalid, Upon follow up the case is assessed as valid.   This is a literature report for the following literature source(s).  A female patient in her 20's received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1,Single), for COVID-19 immunisation. The following information was reported: LYMPHOMATOID PAPULOSIS (medically significant), outcome "recovering", described as "Lymphomatoid papulosis type A"; CONDITION AGGRAVATED (medically significant), outcome "recovering", described as "Dose 2, Progressed(Multiple papules)". The patient underwent the following laboratory tests and procedures: CD30 expression: positive; Histology: Performed; SARS-CoV-2 test: Unknown result. Therapeutic measures were taken as a result of lymphomatoid papulosis, condition aggravated.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202200032690 Same article/ drug and different patient/event.;US-PFIZER INC-202201018007 Same article/ drug and different patient/event.;US-PFIZER INC-202201018008 Same article/ drug and different patient/event.;US-PFIZER INC-202201018009 Same article/ drug and different patient/event.;US-PFIZER INC-202201018010 Same article/ drug and different patient/event.;
Child fainted and was unconscious for about 1 minute.  The child also complained that her stomach hurt.
The Pfizer Covid injection was mixed incorrectly. Instead of 1.8 ml of 0.9% sodium chloride is was diluted with 0.9 ml. was called and spoke to pharmacist was directed to call Pfizer. Pfizer was called option three. Pfizer's recommendation was to follow CDC recommendation which indicates no harm to patient. Also reported states no adverse reaction has been reported. Only report was very sore arm for three to four days at site of injection. Patient's daughter notified.
dehydration; slight fever (99); chills; passed out in floor; sweating; Broke a tooth; Dizzy; Diarrhea; Super tired and went to bed by 8pm after COVID-19 vaccine; Arm was sore; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on 24Feb2021 at 15:00, at single dose, for COVID-19 immunisation. Medical history and concomitant medications were none. Patient did not have known allergies. Patient did not receive any other vaccine the same day and in four weeks. Patient did not have COVID-19 prior to vaccination. The patient experienced passed out in floor (medically significant) on 24Feb2021 at 10:30 PM, diarrhea (disability) on 24Feb2021, broke a tooth (medically significant) on 24Feb2021 at 10:30 PM, dehydration (disability) on 25Feb2021 12:00 AM, slight fever (99) (disability) on 25Feb2021 at 12:00 AM, chills (disability) on 24Feb2021 at 10:30 PM, super tired and went to bed by 08:00 PM after COVID-19 vaccine (non-serious) on 24Feb2021, arm was sore (non-serious) on 24Feb2021, sweating (non-serious) on 24Feb2021 at 10:30 PM, dizzy (non-serious) on 24Feb2021. No therapeutic measures were taken as a result of the events. Patient stated that all side effects resolved completely by 25Feb2021 evening, except for broke a tooth. Patient did not tested positive for COVID-19 post vaccination.  The information on the Lot/Batch number has been requested.
lt leg was severely swollen, w/fever & 2 bruises;t100.8 ax;A large amount of liquid seeped out of inj site & top layer of skin red & plumped;pt screamed for hr;pt up entire noc;appetite dec;eyes glassy & fixed;pale
Information has been received from a medical assistant concerning a 27 month old female patient with no pertinent medical history or drug reactions/allergies who on 18-SEP-2009 was vaccinated with a dose of VARIVAX (Merck) (lot number 665110/1014Y). There was no concomitant therapy. On 17-SEP-2010, 4 days ago, the patient developed a papular, vesicular rash. The rash was all over her body but worse on her legs. The patient sought medical attention by seeing in office. There was no lab diagnostic test performed. The patient was treated with TYLENOL and BENADRYL. At the time of report the patient's status was not recovered. Follow-up information has been received from the medical assistant concerning the female patient (birth weight 8 lb and 4 ounce, no siblings) with no medical history, birth defects or allergies, and no illness at the time of report who on 18-SEP-2009 was vaccinated SQ with the first dose of VARIVAX (Merck) (lot # 665110/1014Y) into the right arm. Secondary suspect therapy included VAQTA (MSD) (lot # 663914/0267Y) IM into the left arm on 18-SEP-2009. Other concomitant therapy included ACTHIB. On 19-SEP-2010 (also reported as 20-SEP-2010), the patient developed rash papular vesicular lesions (worse on her legs) which scattered all over. The patient also developed cellulitis in her left forearm. The medical assistant also reported that on 20-OCT-2010 the patient developed scattered vesicles from legs to the arms and cellulitis on arm. The patient was given KEFLEX. The patient was seen by a dermatologist. On an unspecified date in 2010, the patient recovered. Additional information is not expected.
Patient administered 2nd dose of Moderna Covid 19 vaccine on May 3rd 2021. Patient received the 1st dose of the vaccine at a different location on April 12th, 2021. Therefore, the vaccine was administered early. Patient reported no adverse effects verbally over telephone.
patient fainted for a quick second while seated about 2 minutes post vaccine, she was warm and clammy, she had not eaten all day and was nervous at time of administration.
Breakthrough case admission after 5 vaccines Pfizer 2/25/21 lot# EN6202;  Pfizer 3/18/21 lot# EN6202;  PFizer 11/3/21 lot# FF8841;  Pfizer 4/13/22 lot# FK9896;  Pfizer 11/14/22 lot# GJ3277
Felt different; Sore shoulder; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Felt different), ARTHRALGIA (Sore shoulder), HEADACHE (Headache) and CHILLS (Chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Felt different), ARTHRALGIA (Sore shoulder), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, DISCOMFORT (Felt different), ARTHRALGIA (Sore shoulder), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.    Reporter did not allow further contact
ringing in the ears, sounding like a turban engine constant ringing in the ears -tinnitus